In pharmacies in 58 Russian regions, the drug “Kalimate”, which is necessary for people on dialysis, has disappeared, which is the only drug registered in the country for lowering the level of potassium in the blood. Its high concentration can cause problems with the heart and be fatal. reported “News“.
According to the chairman of the board of Nephro-League, Galina Goretskaya, “Kalimate” is required by almost every patient who undergoes dialysis therapy. This medicine prevents the development of hyperkalemia, which causes abnormal heart rhythms.
“Interruptions in the supply of the drug are critical; dialysis patients should receive it using free prescriptions through pharmacies. Prescribing a potassium sorbent makes it possible to more effectively treat hyperkalemia and prevent its occurrence.”she explained.
As the press service of the R-Pharm company, which produces the drug, explained to journalists, the company fulfills its obligations in full and over the past week has shipped over 10,000 packages of the drug.
The press service of the Ministry of Health, in turn, stated that supplies of the drug in the regions should be enough for ten months, and the last batch of Kalimate was released into civilian circulation on February 29.
